Caribou Biosciences Inc.

In News

Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate - BioPharma Dive

BioPharma Dive - Oct 07, 2026

Caribou Biosciences stock plunges 40% on halt of CAR-T programs - Yahoo Finance

Yahoo Finance - Oct 06, 2026

A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs - Inc.com

Inc.com - Oct 07, 2026

Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road - MedCity News

MedCity News - Oct 07, 2026

Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs - Pharmaceutical Executive

Pharmaceutical Executive - Oct 07, 2026

Caribou Biosciences to Evaluate Strategic Alternatives - Investing News Network

Investing News Network - Oct 06, 2026

An East Bay biotech's 15-year journey from groundbreaking startup to potential selloff - The Business Journals

The Business Journals - Oct 09, 2026

Layoff Tracker: GSK plans to lay off 1.2K+ in Belgium - BioSpace

BioSpace - Oct 15, 2026

Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside - TradingView

TradingView - Aug 14, 2026

CRBU News | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill

ChartMill - Sep 26, 2026

Caribou Bio halts both CAR-T programs and launches sale process amid funding challenges - AllSci

AllSci - Oct 07, 2026

Caribou Biosciences Halts Off-the-Shelf CRISPR CAR-T Programs for Lymphoma and Myeloma After Failing to Fund Phase 3 Trial - Medical Daily

Medical Daily - Oct 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment